Cosmos Health shares are trading higher after the company issued guidance, saying it expects to achieve over $180 million in gross annual revenue and EBITDA in excess of $20 million by 2026.
Portfolio Pulse from Benzinga Newsdesk
Cosmos Health has issued guidance, projecting over $180 million in gross annual revenue and EBITDA exceeding $20 million by 2026. This has led to an increase in the company's share price.
September 12, 2023 | 12:54 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cosmos Health's shares are trading higher after the company issued positive financial guidance for the next five years.
The company's positive financial guidance, projecting significant growth in revenue and EBITDA over the next five years, is likely to instill confidence in investors and drive up the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100